Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Vascular System Injury: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Vascular System Injury: 1 US clinical trial tracked, none currently recruiting.

Vascular System Injury is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Humacyte, running 1 of these trials.

Enrollment posture brief

Registry condition vascular-system-injury

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Vascular System Injury (this)0%
Open-enrollment share among volume-matched conditions near Vascular System Injury

Vascular System Injury has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Vascular System Injury on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Vascular System Injury is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Humacyte 1 trials

Named interventions

Most-linked intervention names on Vascular System Injury records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Human Acellular Vessel (HAV) Biological
1 trials

US sites by state

Facility locations filed on Vascular System Injury trials. A trial with sites in several states counts in each.

New Jersey 1 trials
North Carolina 1 trials
Missouri 1 trials
Minnesota 1 trials
Maryland 1 trials
Georgia 1 trials
Florida 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Vascular System Injury page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Vascular System Injury trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Humacyte sponsors the most Vascular System Injury trials on record, review their full trial history before evaluating a specific study. See Humacyte's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vascular System Injury condition card totals 1 registered trials; most-linked intervention Human Acellular Vessel (HAV); top US site state New Jersey. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.